croservices.joanneum.at

Our Services

We are a full service Contract Research Organization for clinical and preclinical studies together with the Clinical Trial Unit and the Biomedical Research Facility at the Medical University of Graz >.

Data Management

Comprehensive data management services tailored to your clinical and preclinical studies.

Electronic Data Capture (EDC)

Fully validated online system to capture case report forms (CRFs).

Biostatistics

Cost-effective study design and meaningful data by well-designed and thoroughly analyzed studies.

Open flow microperfusion

(Pre)clinical PK/PD/BE studies at the target tissue level using our proprietary OFM technology

Bioanalysis

High resolution, low volume and high-throughput bioanalysis for clinical and preclinical studies.

Metabolomics

Customer-oriented services in the field of metabolomics and metabolic research

Data Visualization

Better interpretation of study results for comprehensive insight into your data by graphical data visualization.

In Vitro Release Testing (IVRT)

Fast and reliable drug release testing by using vitro release testing (IVRT)

Medical Writing

Professional support in reporting and publishing the results of preclinical and clinical studies.

Study results on a short-acting Insulin published

12/17/2020

Credit: JOANNEUM RESEARCH

In a cooperative contract research project, HEALTH and Med Uni Graz have tested a new insulin in a clinical phase 1 study on behalf of Arecor. The study, in which HEALTH was responsible for insulin analysis, statistical evaluation, clinical data management, and quality management, showed that the new insulin enters the bloodstream more quickly and thus also acts faster. As a result, blood glucose control in type 1 diabetics is optimized and dangerous hyper- and hypoglycemia can be avoided. The study results are now published in the top-ranking Journal Diabetes Care.

This new type of fast-acting insulin is an important step in the development of an artificial pancreas. HEALTH is proud to support our clients with new developments to further improve the lives of people with diabetes.